AI and Cancer: Unlocking the Immune System (with Immunai’s Luis Voloch)
Azeem Azhar's Exponential View
00:00
Are You a Circb Service Provider?
We are very conscious of the value that wer retaining of the asset, and that's the main thing we have in mind. We'vehad quite a lot of interest and tem inthese early partnerships around our trunks. So for example, we believe that the specific drug that we have will perform even better when it's combined with a drug from another like large forma company. It can be a winmin for both sides to create, like a drawing programme for putting both of them together. How do you know that that combination would work? Right? You? Where is the data coming from to tell you that, out of all these drugs in the market, this combination may be
Transcript
Play full episode
